FindMyKOL
Clinical trialNCT05301816Active, not recruitingInterventional

PDN Post Market, Multicenter, Prospective, Global Clinical Study

SponsorNevro CorpEnrollment497Diabetic Neuropathy, Painful
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this post-market study is to evaluate the real-world experience of Nevro's Spinal Cord Stimulation (SCS) therapy in patients with chronic, intractable leg pain due to painful diabetic neuropathy (PDN). This is a multicenter, prospective, observational global study, that will partner diabetes management teams with pain physicians to provide an interdisciplinary treatment regimen for PDN patients. Outcomes will be assessed via standardized assessments.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Neuroversion, Inc.

    Anchorage, Alaska, United States

  • Michigan Pain Specialists

    Ann Arbor, Michigan, United States

  • Henry Ford Health

    West Bloomfield, Michigan, United States

  • Ohio State University Wexner Medical Center

    Columbus, Ohio, United States

  • Clinical Investigations, Llc

    Edmond, Oklahoma, United States

  • Columbia Pain Management

    Milwaukie, Oregon, United States

  • Wellspan Interventional Pain Specialists

    York, Pennsylvania, United States

  • Virginia Interventional Pain & Spine Centers

    Roanoke, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
5 Jul 2022
Primary completion
31 Oct 2027
Completion
31 Oct 2028
Last update posted
26 Jun 2026
Registered enrollment
497
Registry id
NCT05301816

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.